Not an actual patient.
For adults with Familial Chylomicronemia Syndrome (FCS),
Reach a new
You’ll love
Introducing Redemplo® (plozasiran)—a new treatment for adults with FCS that works in combination with diet to reduce triglycerides
Data showed patients taking Redemplo® saw a significant reduction in triglycerides, and a lowered incidence of acute pancreatitis, with just one dose every 3 months.
80% Reduction in Triglycerides*,†
A significant median reduction of 80% in triglycerides from baseline was seen at 10 months.
Lowered Acute Pancreatitis Attacks‡
With Redemplo, fewer people had acute pancreatitis attacks: 2 (8%) compared with 5 (20%) on placebo.
Convenient dosing
Redemplo is the only treatment that is just one dose every 3 months.
The safety and effectiveness of Redemplo were studied in a randomized, double-blind, placebo-controlled clinical trial in 75 adult patients with FCS in combination with a low-fat diet (less than or equal to 20 grams of fat per day). The main goal of the trial was to examine how much Redemplo lowered triglycerides from the start of the trial to Month 10 compared with placebo.
Most common adverse reactions were increase in blood sugar levels (hyperglycemia), headache, nausea, and injection site reaction.
*Redemplo 25 mg reduced median triglycerides by 80% (to 443 mg/dL) compared with 17% for placebo (to 1614 mg/dL).
†The median is the middle result in a group of people. This means that half of the patients had results lower than this number and half had results that were higher.
‡The clinical trial included an evaluation of acute pancreatitis events that occurred in patients taking Redemplo compared to those taking placebo. Redemplo has not been proven to reduce acute pancreatitis events.
Support and resources are available with the Rely On Redemplo® Patient Support Program
See how the Rely On Redemplo® Patient Support Program can support your treatment journey.
Learn more
Not an actual patient.
Your experiences with FCS could help others
Share your story Indication and Important Safety Information Collapse
Collapse
INDICATION
REDEMPLO® (plozasiran) is an injectable prescription medicine used together with a low-fat diet to reduce triglycerides (fat in the blood) in adults with a condition that keeps the body from breaking down fats called familial chylomicronemia syndrome (FCS).
IMPORTANT SAFETY INFORMATION
Before you start using REDEMPLO, tell your healthcare provider about all your medical conditions, including if you are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. It is not known if REDEMPLO could harm your unborn baby, or if it passes into your breast milk and could harm your breastfeeding baby.
Tell your healthcare provider or pharmacist about any prescription and over-the-counter medicines, vitamins, or herbal supplements you take.
What are the possible side effects of REDEMPLO?
The most common side effects of REDEMPLO include increased blood sugar levels, headache, nausea, and injection site reactions (pain, redness, or swelling).
These are not all the possible side effects of REDEMPLO. Tell your healthcare provider or treatment team if you have any side effect that bothers you or that does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/safety/medwatch, or call 1-800-FDA-1088.
Please see full Prescribing Information and Patient Product Information for REDEMPLO.